AFX-2721

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAFX-2721
Drug Alias NameAFX-2721
ClassificationSmall molecules
Mechanisms of ActionThymic stromal lymphopoietin inhibitors
TargetsThymic stromal lymphopoietin
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAfecta Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAfecta Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A